Vestcor Inc’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-11,666
Closed -$3K – 1351
2022
Q4
$3K Hold
11,666
– – ﹤0.01% 1219
2022
Q3
$1K Hold
11,666
– – ﹤0.01% 1345
2022
Q2
$1K Hold
11,666
– – ﹤0.01% 1338
2022
Q1
$2K Hold
11,666
– – ﹤0.01% 1406
2021
Q4
$7K Hold
11,666
– – ﹤0.01% 1366
2021
Q3
$7K Hold
11,666
– – ﹤0.01% 1256
2021
Q2
$11K Buy
+11,666
New +$10.9K ﹤0.01% 1257

Vestcor Inc's EBACW Position: Q1 2023 in Review

Vestcor Inc sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 11,666 shares — an estimated $3K sold.

Vestcor Inc first reported a position in EBACW in Q2 2021 and held it in 7 quarters. The position peaked at $11K in Q2 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

  • Vestcor Inc reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
  • Vestcor Inc sold 11,666 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $3K.
  • Vestcor Inc first reported a position in European Biotech Acquisition Corp. Warrant in Q2 2021 and held it in 7 quarters.
  • Vestcor Inc's European Biotech Acquisition Corp. Warrant position peaked at $11K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Vestcor Inc's 13F filing for Q1 2023, filed 15 May 2023.